NIA SBIR Phase I
Supports small businesses developing aging and memory technologies at the feasibility stage.
The National Institute on Aging (NIA) SBIR Phase I program funds feasibility-stage R&D by U.S. small businesses working on aging biology, Alzheimer's disease, and AD-related dementias (AD/ADRD). NIA administers the largest source of early-stage funding for aging-related R&D among all federal agencies, providing approximately $150 million per year in combined SBIR and STTR grants to small businesse…
Phase I feasibility R&D by small businesses in aging biology, Alzheimer's disease, AD-related dementias, and aging-related interventions funded at nearly $150 million annually.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NIA
All grants from this funder →2026 NIA Mentorship Prize Competition
🇺🇸NIA · United States
Pays $100,000 to each of up to six faculty mentors recognized for outstanding aging-research mentorship.
NIA SBIR Phase II
🇺🇸NIA · United States
Funds small businesses advancing aging biology and Alzheimer's disease technologies through full development execution.
NIA STTR Phase I
🇺🇸NIA · United States
Supports small businesses partnering with universities on aging innovation at feasibility stage.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
NIA · United States
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
NIA Start-Up Challenge
🇺🇸NIA · United States
Funds US entrepreneurs and small businesses developing healthy-aging technologies through NIA's Start-Up Challenge cash prizes and accelerator.
Similar grants
Browse the directory →
NIH SBIR Phase I
🇺🇸NIH SEED · United States
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.
NIDCD SBIR Phase I
🇺🇸NIDCD · United States
Supports United States. small businesses developing hearing, balance, and speech sensory technologies.
NINDS SBIR Phase I
🇺🇸NINDS · United States
Funds small-business feasibility research for neuroscience technologies advancing toward later commercialization in the United States.
NSF SBIR Phase I
🇺🇸NSF · United States
Funds United States deep-tech startups demonstrating scientific feasibility of novel science and engineering innovations.
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NCATS SBIR Phase I
🇺🇸NCATS · United States
Supports small businesses testing translational science tools and technologies through early feasibility and commercialization groundwork.